Palisade Bio (PALI)
(Delayed Data from NSDQ)
$0.86 USD
-0.06 (-6.73%)
Updated Sep 30, 2025 04:00 PM ET
After-Market: $0.84 -0.02 (-2.29%) 6:30 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Palisade Bio, Inc. has a market cap of $8.41M, which represents its share price of $0.92 multiplied by its outstanding shares number of 9.12M. As a small-cap company, PALI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PALI 0.86 -0.06(-6.73%)
Will PALI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PALI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PALI
Palisade Bio (PALI) Upgraded to Buy: What Does It Mean for the Stock?
PALI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PALI
Is PALI poised for a decline? 200 Day Moving Average Resistance shows up after gaining 2.62%
Palisade Bio files to sell 147.1M shares of common stock
Palisade Bio files to sell 147.1M shares of common stock
Is PALI ready to move higher? Crossed Above 50 Day Moving Average shows up after rocketing 16.2%
PALI forms Stochastic Reached Overbought on September 25